Stocksigma LogoStocksigma Logo

NGL Fine-Chem Q2FY27 Results: Strong Operating Performance Driven by Volume Growth

NGL Fine-Chem delivered strong Q2FY27 revenue from operations of ₹158.71 Cr, surging 31.97% YoY and 14.05% QoQ, driven by robust volume demand

NGL Fine-Chem Q2FY27 Results: Strong Operating Performance Driven by Volume Growth

NGL Fine Chem Ltd · Investor Presentation · 11 Nov 2026, 4:07 am

NGL Fine-Chem Q2FY27 Results: Strong Operating Performance Driven by Volume Growth NGL Fine-Chem delivered strong Q2FY27 revenue from operations of ₹158.71 Cr, surging 31.97% YoY and 14.05% QoQ, driven by robust volume demand. EBITDA grew 63.52% YoY to ₹28.06 Cr with margins expanding 341 bps YoY to 17.68%. PAT rose 68.74% YoY to ₹16.25 Cr. Animal API contributed 95% of revenues. The company commissioned its Phase-II facility (₹220.72 Cr capex), targeting 30%–40% capacity utilization over 2–3 quarters, while advancing European registration transfers and nine US Veterinary Master File filings for impending USFDA inspection.

Original exchange filing (PDF)

More announcements from NGL Fine Chem Ltd

All NGL Fine Chem Ltd announcements